2021 annual financial data
NewAmsterdam Pharma 2021 Net margin
NewAmsterdam Pharma 2021 net margin with verified reported values.
Direct answer
Net margin was Not calculable.
Operating income was -34,977,000 EUR and net income was -41,785,000 EUR.
Operating cash flow was -29,512,000 EUR.
Get free NewAmsterdam Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 EUR
- Operating income
- -34,977,000 EUR
- Net income
- -41,785,000 EUR
- Operating cash flow
- -29,512,000 EUR